Clinical Trials Directory

Trials / Unknown

UnknownNCT06124274

Oral Contraceptive vs Menstrual Cycle Ex Vivo Model

The Effect of Menstrual Phase and Oral Contraceptives on Muscle Protein Metabolism

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
University of Toronto · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

Despite comprising half the population, females are often left out of muscle research due to the impact of changing hormones during the menstrual cycle and when using oral contraceptives. This makes it hard to perform costly and invasive studies involving tracers to study muscle protein metabolism. Consequently, we lack a clear understanding of how these hormonal changes affect muscle growth. There is a need for less invasive methods to study how sex hormones and oral contraceptives influence muscle protein metabolism. Ex vivo models, where serum from participants is applied to mouse muscle cell cultures, mimic the conditions of human muscle cells and can provide initial insights.

Detailed description

The aim of the study is to develop a non-invasive model using serum from both oral contraceptive users and non-users at various stages of their cycles, to understand if different cycle or pill stages affect how muscles process proteins.

Conditions

Interventions

TypeNameDescription
BEHAVIORALProtein tracer drinkSubjects will be fed a mixed-macronutrient beverage at rest (0.75g/kg lean body mass of carbohydrates; 0.125g/kg lean body mass of protein). Amino acid composition of the protein will be modelled off the composition of egg. Leucine content will be enriched to 5% with \[13 Carbon(13C)\]-leucine.

Timeline

Start date
2023-08-09
Primary completion
2024-09-01
Completion
2024-09-01
First posted
2023-11-09
Last updated
2023-11-09

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06124274. Inclusion in this directory is not an endorsement.

Oral Contraceptive vs Menstrual Cycle Ex Vivo Model (NCT06124274) · Clinical Trials Directory